{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:32:24Z","timestamp":1791189144316,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s40263-015-0262-y","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T12:43:31Z","timestamp":1438692211000},"page":"591-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Antipsychotic Drug Use and the Risk of Seizures: Follow-up Study with a Nested Case\u2013Control Analysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Marlene","family":"Bloechliger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"R\u00fcegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Jick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,5]]},"reference":[{"key":"262_CR1","first-page":"417","volume-title":"Goodman and Gilman\u2019s pharmacological basis of therapeutics","author":"JM Meyer","year":"2011","unstructured":"Meyer JM. Pharmacotherapy of psychosis and mania. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman and Gilman\u2019s pharmacological basis of therapeutics. 12th ed. New York: McGrawHill Medical; 2011. p. 417\u201351.","edition":"12"},{"key":"262_CR2","first-page":"28","volume":"81","author":"F Block","year":"2013","unstructured":"Block F, Dafotakis M. Drug-induced seizures. Fortschr Neurol Psychiatr. 2013;81:28\u201334. doi: 10.1055\/s-0032-1325332 .","journal-title":"Fortschr Neurol Psychiatr"},{"key":"262_CR3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","volume":"25","author":"F Pisani","year":"2002","unstructured":"Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25:91\u2013110.","journal-title":"Drug Saf"},{"key":"262_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14737175.6.4.575","volume":"6","author":"C Ruffmann","year":"2006","unstructured":"Ruffmann C, Bogliun G, Beghi E. Epileptogenic drugs: a systematic review. Expert Rev Neurother. 2006;6:575\u201389. doi: 10.1586\/14737175.6.4.575 .","journal-title":"Expert Rev Neurother"},{"key":"262_CR5","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.1980.03310130038026","volume":"244","author":"TM Itil","year":"1980","unstructured":"Itil TM, Soldatos C. Epileptogenic side effects of psychotropic drugs: practical recommendations. JAMA. 1980;244:1460\u20133.","journal-title":"JAMA"},{"key":"262_CR6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/WNL.17.9.869","volume":"17","author":"J Logothetis","year":"1967","unstructured":"Logothetis J. Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology. 1967;17:869\u201377.","journal-title":"Neurology"},{"key":"262_CR7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1517\/14740338.4.4.731","volume":"4","author":"J Fitzsimons","year":"2005","unstructured":"Fitzsimons J, Berk M, Lambert T, Bourin M, Dodd S. A review of clozapine safety. Expert Opin Drug Saf. 2005;4:731\u201344. doi: 10.1517\/14740338.4.4.731 .","journal-title":"Expert Opin Drug Saf"},{"key":"262_CR8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1358\/dot.2003.39.7.799445","volume":"39","author":"D Hedges","year":"2003","unstructured":"Hedges D, Jeppson K, Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today (Barc). 2003;39:551\u20137.","journal-title":"Drugs Today (Barc)"},{"key":"262_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","volume":"62","author":"K Alper","year":"2007","unstructured":"Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345\u201354. doi: 10.1016\/j.biopsych.2006.09.023 .","journal-title":"Biol Psychiatry"},{"key":"262_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","volume":"29","author":"AM Williams","year":"2015","unstructured":"Williams AM, Park SH. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs. 2015;29:101\u201311. doi: 10.1007\/s40263-014-0222-y .","journal-title":"CNS Drugs"},{"key":"262_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.seizure.2009.11.005","volume":"19","author":"E Kumlien","year":"2010","unstructured":"Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure. 2010;19:69\u201373. doi: 10.1016\/j.seizure.2009.11.005 .","journal-title":"Seizure"},{"key":"262_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2012.10.009","volume":"22","author":"U Lertxundi","year":"2013","unstructured":"Lertxundi U, Hernandez R, Medrano J, Domingo-Echaburu S, Garc\u00eda M, Aguirre C. Antipsychotics and seizures: higher risk with atypicals? Seizure. 2013;22:141\u20133. doi: 10.1016\/j.seizure.2012.10.009 .","journal-title":"Seizure"},{"key":"262_CR13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(05)70451-7","volume":"350","author":"H Jick","year":"1997","unstructured":"Jick H. A database worth saving. Lancet. 1997;350:1045\u20136. doi: 10.1016\/S0140-6736(05)70451-7 .","journal-title":"Lancet"},{"key":"262_CR14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/qjmed\/91.6.445","volume":"91","author":"DH Lawson","year":"1998","unstructured":"Lawson DH, Sherman V, Hollowell J. The general practice research database: Scientific and Ethical Advisory Group. QJM. 1998;91:445\u201352.","journal-title":"QJM"},{"key":"262_CR15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200427120-00004","volume":"27","author":"L Wood","year":"2004","unstructured":"Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf. 2004;27:871\u201381.","journal-title":"Drug Saf"},{"key":"262_CR16","unstructured":"The Clinical Practice Research Datalink. http:\/\/www.cprd.com . Accessed 15 July 2015."},{"key":"262_CR17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol. 2010;69:4\u201314. doi: 10.1111\/j.1365-2125.2009.03537.x .","journal-title":"Br J Clin Pharmacol"},{"key":"262_CR18","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the general practice research database: a systematic review. Br J Gen Pract. 2010;60:e128\u201336. doi: 10.3399\/bjgp10X483562 .","journal-title":"Br J Gen Pract"},{"key":"262_CR19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/pds.3699","volume":"23","author":"C Ishiguro","year":"2014","unstructured":"Ishiguro C, Wang X, Li L, Jick S. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case\u2013control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014;23:1168\u201375. doi: 10.1002\/pds.3699 .","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"16","key":"262_CR20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/eurheartj\/ehu263","volume":"36","author":"R Brauer","year":"2015","unstructured":"Brauer R, Smeeth L, Anaya-Izquierdo K, Timmis A, Denaxas SC, Farrington CP, et al. Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study. Eur Heart J. 2015;36(16):984\u201392. doi: 10.1093\/eurheartj\/ehu263 .","journal-title":"Eur Heart J"},{"key":"262_CR21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1532-5415.2011.03479.x","volume":"59","author":"L Laredo","year":"2011","unstructured":"Laredo L, Vargas E, Blasco AJ, Aguilar MD, Moreno A, Portol\u00e9s A. Risk of cerebrovascular accident associated with use of antipsychotics: population-based case\u2013control study. J Am Geriatr Soc. 2011;59:1182\u20137. doi: 10.1111\/j.1532-5415.2011.03479.x .","journal-title":"J Am Geriatr Soc"},{"key":"262_CR22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/epi.12045","volume":"54","author":"P Imfeld","year":"2013","unstructured":"Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR. Seizures in patients with Alzheimer\u2019s disease or vascular dementia: a population-based nested case\u2013control analysis. Epilepsia. 2013;54:700\u20137. doi: 10.1111\/epi.12045 .","journal-title":"Epilepsia"},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2009.08.006","volume":"87","author":"C Martinez","year":"2009","unstructured":"Martinez C, Sullivan T, Hauser WA. Prevalence of acute repetitive seizures (ARS) in the United Kingdom. Epilepsy Res. 2009;87:137\u201343. doi: 10.1016\/j.eplepsyres.2009.08.006 .","journal-title":"Epilepsy Res"},{"key":"262_CR24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1592\/phco.20.7.629.35174","volume":"20","author":"C Gasse","year":"2000","unstructured":"Gasse C, Derby L, Vasilakis-Scaramozza C, Jick H. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy. 2000;20:629\u201334.","journal-title":"Pharmacotherapy"},{"key":"262_CR25","first-page":"241","volume":"12","author":"SS Jick","year":"1992","unstructured":"Jick SS, Jick H, Knauss TA, Dean AD. Antidepressants and convulsions. J Clin Psychopharmacol. 1992;12:241\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"262_CR26","doi-asserted-by":"crossref","unstructured":"Nasrallah H, Tandon R. Classic antipsychotic medications. In: Schatzberg A, Nemeroff C (eds) The American psychiatric publishing textbook of psychopharmacology, 4th edn. Arlington; 2009. p. 533\u201354.","DOI":"10.1176\/appi.books.9781585623860.as27"},{"key":"262_CR27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.23601","volume":"72","author":"DC Hesdorffer","year":"2012","unstructured":"Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72:184\u201391. doi: 10.1002\/ana.23601 .","journal-title":"Ann Neurol"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/schbul\/23.4.611","volume":"23","author":"TM Hyde","year":"1997","unstructured":"Hyde TM, Weinberger DR. Seizures and schizophrenia. Schizophr Bull. 1997;23:611\u201322.","journal-title":"Schizophr Bull"},{"key":"262_CR29","unstructured":"World Health Organization. ATC\/DDD Index 2015. 2015. http:\/\/www.whocc.no\/atc_ddd_index\/ . Accessed 15 July 2015."},{"key":"262_CR30","first-page":"334","volume":"86","author":"JA Wilden","year":"2012","unstructured":"Wilden JA, Cohen-Gadol AA. Evaluation of first nonfebrile seizures. Am Fam Physician. 2012;86:334\u201340.","journal-title":"Am Fam Physician"},{"key":"262_CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1517\/14740338.2.3.233","volume":"2","author":"KC Lee","year":"2003","unstructured":"Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf. 2003;2:233\u201347.","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl 2","key":"262_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1528-1157.2002.043s2019.x","volume":"43","author":"S Koch-Stoecker","year":"2002","unstructured":"Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia. 2002;43(Suppl 2):19\u201324.","journal-title":"Epilepsia"},{"key":"262_CR33","unstructured":"National Institute for Health and Care Excellence. Low-dose antipsychotics in people with dementia. 2015. http:\/\/www.nice.org.uk\/advice\/ktt7\/resources\/non-guidance-lowdose-antipsychotics-in-people-with-dementia-pdf . Accessed 15 July 2015."},{"key":"262_CR34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/WNL.41.3.369","volume":"41","author":"O Devinsky","year":"1991","unstructured":"Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology. 1991;41:369\u201371.","journal-title":"Neurology"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0262-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-015-0262-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0262-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:24Z","timestamp":1559504484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-015-0262-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s40263-015-0262-y","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}